Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML
NCT03537560
·
clinicaltrials.gov ↗
COMPLETED
Status
334
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Sponsor
Chang Gung Memorial Hospital